CVE:PAS

Pascal Biosciences Inc. (PAS.V) Stock Forecast, Price & News

C$0.10

-0.01 (-4.55 %)

(As of 01/19/2021 02:43 PM ET)

Add

Compare

Today's Range

C$0.11

Now: C$0.11▼

C$0.12

50-Day Range

C$0.00

MA: C$0.14▼

C$0.16

52-Week Range

C$0.07

Now: C$0.11▼

C$0.45

Volume25,850 shs

Average Volume95,961 shs

Market CapitalizationC$6.05 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Pascal Biosciences Inc., a biopharmaceutical company, researches and develops products for the treatment of cancer, and for the enhancement of immune system. Its development portfolio includes PAS-403, a small molecule therapeutic advancing into clinical trials for the treatment of glioblastoma; and PAS-393, an immuno-stimulatory molecule to enhance the efficacy of checkpoint inhibitors. The company is also developing a B-cell targeted antibody for acute lymphoblastic leukemia and B cell lymphomas. The company has an exclusive license agreement with the University of Washington to develop a cannabinoid-based product for the treatment of glioblastoma multiforme and brain metastases; and a collaborative research agreement with SoRSE Technology Corporation to advance PAS-393 into clinical testing. Pascal Biosciences Inc. was founded in 2013 and is headquartered in Vancouver, Canada.

Overall MarketRank^™

0.56 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Pascal Biosciences Inc. (PAS.V).

2.8 Community Rank

Outperform Votes
Pascal Biosciences Inc. (PAS.V) has received 55 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Pascal Biosciences Inc. (PAS.V) has received 42 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Pascal Biosciences Inc. (PAS.V) has received 56.70% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Pascal Biosciences Inc. (PAS.V) and other stocks. Vote “Outperform” if you believe PAS will outperform the S&P 500 over the long term. Vote “Underperform” if you believe PAS will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Pascal Biosciences Inc. (PAS.V) does not currently pay a dividend.
Dividend Growth
Pascal Biosciences Inc. (PAS.V) does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Pascal Biosciences Inc. (PAS.V) insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Pascal Biosciences Inc. (PAS.V) is -3.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Pascal Biosciences Inc. (PAS.V) is -3.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

See Top Rated MarketRank™ Stocks Here

Industry, Sector and Symbol

Stock Exchange CVE

Industry Biotechnology

Sub-IndustryN/A

SectorMedical

Current SymbolCVE:PAS

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.biommune.net

Phone+1-604-6886775

Employees5

Debt

Debt-to-Equity RatioN/A

Current Ratio0.20

Quick Ratio0.16

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowC$0.00 per share

Price / Cash Flow100.00

Book ValueC($0.01) per share

Price / Book-15.00

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding Shares57,595,000

Market CapC$6.05 million

Next Earnings DateN/A

OptionableNot Optionable

C$0.10

-0.01 (-4.55 %)

(As of 01/19/2021 02:43 PM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive PAS News and Ratings via Email

Sign-up to receive the latest news and ratings for PAS and its competitors with MarketBeat's FREE daily newsletter.

Pascal Biosciences Inc. (PAS.V) (CVE:PAS) Frequently Asked Questions

How has Pascal Biosciences Inc. (PAS.V)'s stock been impacted by Coronavirus (COVID-19)?

Pascal Biosciences Inc. (PAS.V)'s stock was trading at C$0.10 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, PAS shares have increased by 5.0% and is now trading at C$0.11.
View which stocks have been most impacted by COVID-19.

What stocks does MarketBeat like better than Pascal Biosciences Inc. (PAS.V)?

Wall Street analysts have given Pascal Biosciences Inc. (PAS.V) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Pascal Biosciences Inc. (PAS.V) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Pascal Biosciences Inc. (PAS.V)'s key competitors?

Some companies that are related to Pascal Biosciences Inc. (PAS.V) include OptiBiotix Health Plc (OPTI.L) (OPTI), SkinBioTherapeutics Plc (SBTX.L) (SBTX), Microbix Biosystems Inc. (MBX.TO) (MBX), Hvivo (HVO), IXICO plc (IXI.L) (IXI), Covalon Technologies Ltd. (COV.V) (COV), Tissue Regenix Group plc (TRX.L) (TRX), Hemogenyx Pharmaceuticals Plc (HEMO.L) (HEMO), Emerald Health Therapeutics, Inc. (EMH.V) (EMH), Rua Life Sciences Plc (RUA.L) (RUA), Fusion Antibodies plc (FAB.L) (FAB), ImmuPharma plc (IMM.L) (IMM), IntelGenx Technologies Corp. (IGX.V) (IGX), ProMIS Neurosciences, Inc. (PMN.TO) (PMN) and Collagen Solutions plc (COS.L) (COS).
View all of PAS's competitors.

What other stocks do shareholders of Pascal Biosciences Inc. (PAS.V) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pascal Biosciences Inc. (PAS.V) investors own include Aurora Cannabis Inc. (ACB.TO) (ACB), Canadian Natural Resources Limited (CNQ.TO) (CNQ), Corus Entertainment (CJR), Auxly Cannabis Group (CBWTF), Grande West Transportation Group Inc (BUS.V) (BUS), Bausch Health Companies (BHC), Abattis Bioceuticals (ATT), Algonquin Power & Utilities Corp. (AQN.TO) (AQN), Aphria Inc. (APHA.TO) (APHA) and Abacus Mining & Exploration Co. (AME.V) (AME).

Who are Pascal Biosciences Inc. (PAS.V)'s key executives?

Pascal Biosciences Inc. (PAS.V)'s management team includes the following people:

Dr. Patrick W. Gray, CEO & Director (Age 69, Pay $256.57k)
Ms. Judith F. Dalling L.L.B., CFO & Corp. Sec. (Age 66, Pay $65k)

What is Pascal Biosciences Inc. (PAS.V)'s stock symbol?

Pascal Biosciences Inc. (PAS.V) trades on the Canadian Venture Exchange (CVE) under the ticker symbol "PAS."

How do I buy shares of Pascal Biosciences Inc. (PAS.V)?

Shares of PAS and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What is Pascal Biosciences Inc. (PAS.V)'s stock price today?

One share of PAS stock can currently be purchased for approximately C$0.11.

How big of a company is Pascal Biosciences Inc. (PAS.V)?

Pascal Biosciences Inc. (PAS.V) has a market capitalization of C$6.05 million. Pascal Biosciences Inc. (PAS.V) employs 5 workers across the globe.

What is Pascal Biosciences Inc. (PAS.V)'s official website?

The official website for Pascal Biosciences Inc. (PAS.V) is www.biommune.net.

How can I contact Pascal Biosciences Inc. (PAS.V)?

Pascal Biosciences Inc. (PAS.V)'s mailing address is 400 Burrard St Suite 1780, VANCOUVER, BC V6C 3A6, Canada. The company can be reached via phone at +1-604-6886775.

This page was last updated on 1/19/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Pascal Biosciences Inc. (PAS.V) Stock Forecast, Price & News

Adding

Adding

Adding Pascal Biosciences Inc. (PAS.V)

MarketRank™

Overall MarketRank™